Meeting
2012 Breast Cancer Symposium
Sonodynamic and photodynamic therapy in advanced refractory breast cancer.
Authors
Xiaohuai Wang
Liu Hua Qiao Hospital
Xiaohuai Wang , Lucy Li , Weimin Zhang , Yifan Luo , Douglas Mitchell
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C
Track
Survivorship and Health Policy,Systemic Therapy
Sub Track
Advanced Disease
Citation
J Clin Oncol 30, 2012 (suppl 27; abstr 118)
DOI
10.1200/jco.2012.30.27_suppl.118
Abstract #
118
Poster Bd #
B10
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
A phase II trial of an oral CDK 4/6 inhibitor, PD0332991, in advanced breast cancer.
First Author: Angela DeMichele
Poster
2023 ASCO Annual Meeting
Phase 3 RCT of dexamethasone versus placebo for chemotherapy induced fatigue in patients with advanced solid malignancies.
First Author: Venkatraman Radhakrishnan
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Phase II trial of cabozantinib (Cabo) plus durvalumab (Durva) in chemotherapy refractory patients with advanced mismatch repair proficient/microsatellite stable (pMMR/MSS) colorectal cancer (CRC): CAMILLA CRC cohort results.
First Author: Anwaar Saeed
Poster
2021 ASCO Annual Meeting
Trial in progress: A phase 1b study of sotorasib, a specific and irreversible KRASG12C inhibitor, as monotherapy in non-small cell lung cancer (NSCLC) with brain metastasis and in combination with other anticancer therapies in advanced solid tumors (CodeBreaK 101).
First Author: David S. Hong